Damage caused by neurofibrillary tangles or Aβ protein could be reduced via masitinib's targeting of Fyn or the FAK pathway, kinases that have been implicated in the phosphorylation pathway of Tau protein and Aβ-induced cognitive impairment [24-26]. Here, FYN is linked to Cognitive impairment.